On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
Seeing Green: CMMI Announces More Money for State Innovation
Of these grant funds, $50 million will be allocated for Model Design awards granted to up to 25 states in order to “determine what type of system improvements would work best for them.” Meanwhile, the vast majority of the funds—$225 million—will be allocated to Model Testing awards provided to up to five states with projects that are ready to go for purposes of program implementation. Recipients of these Model Testing awards will generally be expected to pursue models similar to those already endorsed by CMS (e.g., accountable care organizations); although, CMS has indicated a willingness to back alternative ideas from implementation grant recipients, such as Medicaid waivers.
Additional information about the initiative is available at: http://innovation.cms.gov/initiatives/state-innovations/. CMMI also plans to host a webinar on Thursday, July 26, 2012, from 3:00 to 4:00 PM, EST, to provide an overview of the State Innovation Models Initiative. To find out more information about the webinar, including how to register, visit: http://innovations.cms.gov/resources/State-Innovation-Model-Overview.html.
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017